MCK — McKesson Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual income statement for McKesson, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	231,051	238,228	263,966	276,711	308,951
Cost of Revenue
Gross Profit	12,023	12,284	13,286	12,358	12,584
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	228,148	243,268	262,119	272,330	305,033
Operating Profit	2,903	-5,040	1,847	4,381	3,918
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,144	-5,034	1,928	4,630	3,789
Provision for Income Taxes
Net Income After Taxes	1,126	-4,339	1,292	3,725	3,160
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	900	-4,539	1,114	3,560	3,002
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	900	-4,539	1,114	3,560	3,002
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	6.13	7.05	13.4	26	22.4
Dividends per Share